secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001104659-23-059138
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaccitech shareholders approve all proposals at 2023 AGM
--------------------------------------------------------

- Re-elected directors Karen T. Dawes (18.8M for) and Anne M. Phillips (19.7M for).
- Re-appointed PricewaterhouseCoopers LLP as UK statutory auditors (19.7M for).
- Ratified PwC as independent registered public accounting firm for FY2023 (19.7M for).
- Approved advisory vote on directors' compensation report (19.7M for).
- Received annual accounts for FY2022; no dividend recommended (19.7M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465923059138/0001104659-23-059138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465923059138/tm2315505d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-059138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer